Dan Rosenberg
Ticker Tape Contributor

About Dan Rosenberg

Dan Rosenberg has been senior writer for The Ticker Tape® since 2016. Dan spent nearly a decade (1996–2005) covering corporate news and markets for Dow Jones Newswires; his articles frequently appeared in The Wall Street Journal and Barron’s. He also spent almost a decade working in public relations, including six years as spokesman for a Fortune 500 health care company.

Dan is a successful fiction writer, earning the Illinois “Soon To Be Famous” author’s award in 2017 for his novel, The Towers Still Stand.

He holds an MA from the Medill School of Journalism at Northwestern University and a BA in history from Knox College.

 

Get Dan’s perspective

Alzheimer’s Approval, COVID-19 Vaccines Put Spotlight on Biotech Sector, but What’s Next? July 21, 2021 10:15 AM   |  

FDA approval of Biogen’s Alzheimer’s drug plus COVID-19 vaccines and gene editing put biotech investing back in the spotlight. But it’s still a long game for investors.

5 min read  |  Sector Outlooks
With Crude Near 3-Year Highs, Should Investors Worry About $100 Oil? July 12, 2021 10:15 AM   |  

The crude oil market has reached highs due to supply bottlenecks, travel resurgence, and pressure on drillers. Will it reach $100 per barrel?

5 min read  |  Economic Trends
Trying to Time the Market? Consider the Importance of Staying Invested June 18, 2021 10:15 AM   |  

Even long-term investors can sometimes use timing strategies to go in and out of the market, but spending long-term time in the market could beat timing the market.

5 min read  |  Portfolio Strategy
Big Purchase Ahead? Think of Potential Short-Term Investment Strategies June 14, 2021 2:14 PM   |  

If a big expense is staring you down, here are some important things to keep in mind when deciding how to invest for that shorter-term goal.

5 min read  |  Savings Goals
Connecting the Dots: Investor Guide to Tracking Fed Policy Projections with the Dot Plot May 24, 2021 10:15 AM   |  

The Fed provides a quarterly “dot plot” with its monetary policy projections for the next several years that can help investors glean the Fed’s thinking about the future.

5 min read  |  Federal Reserve
Renewable Energy, Shipping, Health Care? Welcome to Biden’s Infrastructure Plan May 12, 2021 10:15 AM   |  

A new $2 trillion infrastructure plan is making its way through Washington, leading many investors to seek new opportunities. But which sectors will get a boost?

6 min read  |  Stocks & Stock Sectors
Capiche: Why Are You Getting In a Trade? April 5, 2021 10:30 AM   |  

Successful traders have rules and stick to them, whether those rules are based on volatility, probability, technical analysis, or other factors.

1 min read  |  thinkMoney Magazine
What Is Gross Domestic Product (GDP)? Measuring the Nation’s Economic Output March 17, 2021 1:46 PM   |  

Gross domestic product (GDP) data is one key to understanding U.S. economic health. It’s a closely watched number that can affect fiscal and monetary policy as well as corporate planning and strategy.

4 min read  |  Fundamental Analysis
Fiscal Stimulus and Portfolio Strategy: Sail Toward the Action or Stay the Course? March 9, 2021 3:34 PM   |  

Policy makers often use fiscal stimulus to stoke the economic embers and guide the economy toward long-term policy aims. Should you incorporate cues from fiscal spending into your portfolio strategy?

5 min read  |  Portfolio Strategy
The Short and Long of It: Your Top Questions on Short-Selling Answered February 8, 2021 2:01 PM   |  

Short selling, short interest, naked short selling are among terms some investors had scarcely paid attention to. But a flurry of apparent short squeezes in 2021 called attention to shorting. Here are some of the top questions answered.

6 min read  |  Margin
Call Us
800-454-9272

Content intended for educational/informational purposes only. Not investment advice, or a recommendation of any security, strategy, or account type.

Be sure to understand all risks involved with each strategy, including commission costs, before attempting to place any trade. Clients must consider all relevant risk factors, including their own personal financial situations, before trading.

adChoicesAdChoices

Market volatility, volume, and system availability may delay account access and trade executions.

Past performance of a security or strategy does not guarantee future results or success.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses. Options trading subject to TD Ameritrade review and approval. Please read Characteristics and Risks of Standardized Options before investing in options.

Supporting documentation for any claims, comparisons, statistics, or other technical data will be supplied upon request.

This is not an offer or solicitation in any jurisdiction where we are not authorized to do business or where such offer or solicitation would be contrary to the local laws and regulations of that jurisdiction, including, but not limited to persons residing in Australia, Canada, Hong Kong, Japan, Saudi Arabia, Singapore, UK, and the countries of the European Union.

TD Ameritrade, Inc., member FINRA/SIPC, a subsidiary of The Charles Schwab Corporation. TD Ameritrade is a trademark jointly owned by TD Ameritrade IP Company, Inc. and The Toronto-Dominion Bank. © 2021 Charles Schwab & Co. Inc. All rights reserved.

Scroll to Top